Koch Disruptive Technologies

?? Big congratulations to Sidecar Health for being named one of Fierce Healthcare's "Fierce 15" companies of 2025! ?? As one of the most innovative companies transforming healthcare, Sidecar Health is redefining how people access and pay for care—bringing transparency, affordability, and consumer choice to the forefront. We are proud to support and work alongside Sidecar Health as they continue to make a lasting effect in the industry. Read more about this incredible recognition here: https://lnkd.in/eV4rfsFu #Fierce15 #HealthcareInnovation #SidecarHealth #FutureofHealthcare

Our portfolio company Bitterroot Bio, pioneers in cardiovascular medicine, recently completed the Phase 1 first-in-human study of its new BRB-002 protein therapy for atherosclerotic cardiovascular disease. The innovative treatment was safe at all doses tested in healthy volunteers. The Phase 2 trial in patients with atherosclerosis is planned for the first half of 2025, a major next milestone for the company! Read the full press release here: https://lnkd.in/gEr4Er5U

? Transforming Enterprise Modernization with Rhino.ai and Koch Disruptive Technologies! ? KDT is thrilled to support Rhino.ai's mission to revolutionize enterprise modernization through its groundbreaking AI-powered platform. Rhino.ai empowers businesses to seamlessly transition outdated systems into agile, scalable solutions by dramatically reducing modernization timelines. "Rhino.ai 's innovative approach to legacy system modernization aligns perfectly with the urgent need for digital transformation across industries," said Byron Knight, President of Koch Disruptive Technologies. By integrating Rhino.ai’s innovative platform with Koch’s vast network and experience, we’re creating mutual benefits for Koch as a customer and our partners. This collaboration ensures organizations can navigate the complexities of digital transformation with enhanced ease and precision. ?? Learn more about this transformative collaboration: https://lnkd.in/eE5yhmAx #EnterpriseModernization #Innovation #DigitalTransformation #AI #RhinoAI #KochDisruptiveTechnologies #KDT #StrategicPartnership

Congratulations to the team at Valo Health, a KDT portfolio company, on their expanded partnership with Novo Nordisk. By leveraging AI and real-world human data, this collaboration aims to deliver groundbreaking treatments for obesity, type 2 diabetes, and cardiovascular disease, marking a significant step forward in patient care. KDT is thrilled to support Valo on their quest to revolutionize precision therapeutics and improve health outcomes for patients worldwide. https://lnkd.in/eQYgQ38E

Big News at Cellares! Congratulations to Cellares, on the exciting appointment of Ossama Eissa as their new Chief Operating Officer! With Ossama’s 20+ years of expertise in biotech manufacturing at top companies like Novartis, Lonza Biologics, and Legend Biotech, Cellares is poised to make even greater strides in advancing access to life-saving cell therapies. As Cellares continues to scale globally and leverage their advanced automated Cell Shuttle? and Cell Q? platforms, we are proud to support them in their mission to bring innovative therapies to patients who need them most. https://lnkd.in/gpVkiFBk #Cellares #Partnership #CellTherapy #HealthcareInnovation #Leadership #GlobalExpansion

Congratulations to Oshi Health, a KDT portfolio company, on raising $60M in Series C funding! This is an important milestone on their journey to revolutionize digestive healthcare with a patient-centric approach that provides faster access to care, material improvements in outcomes and patient satisfaction while providing significant savings to employers and health plans.? ? Through KDT’s collaboration with the Koch Benefits team, we’ve leveraged our partnership with Oshi Health to bring their innovative solutions in specialized gastrointestinal care to Koch’s U.S.-based employees. ? We are excited to support Oshi Health and look forward to the meaningful changes our continued partnership will bring. ?

Exciting news from OneLayer, a KDT portfolio company! OneLayer, a leader in enterprise private 5G/LTE OT network management and security, has formed a strategic partnership with World Wide Technology. This collaboration is set to transform private cellular solutions, enhancing operational efficiency and ensuring zero-trust security for enterprises. In addition, Evergy has selected OneLayer to manage and secure its expanding private cellular network, using the OneLayer Bridge platform to maximize operational efficiency and secure OT assets. Congratulations to the OneLayer team on these remarkable achievements! Check the comments for links to the full press releases.

A fantastic achievement for the entire Cellares team!? ? We are proud to partner with the company as they continue to execute on their mission to bring lifesaving cell therapies to more patients, at lower costs.?

KDT is committed to empowering our portfolio companies like Celestial AI to unlock their full potential. That’s why we have established a powerful connection between Koch Labs? and subject matter experts across Koch. From technology to operation, finance and more, our network is able to provide valuable guidance and support to our portfolio companies. By leveraging the knowledge and resources available through Koch Labs, our partners can focus on what they do best - growing their business. Learn how Celestial AI is enabling faster and more efficient communication within computer systems: https://www.celestial.ai/

Congratulations?to the team at Astranis Space Technologies, a KDT portfolio company, on raising a $200 million Series D! Their innovative low-cost telecommunications satellites are set to unlock previously unreachable locations.? ? We’re excited to be a part of Astranis and their mission to connect the world.